Blood Results - 2 years on Finasteride, 1 year on dutasteride
    Research/Science 3/25/2025

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’Š Finasteride (oral) 2 years
    ๐Ÿ’Š Dutasteride (oral) 1 year
    the tone is ๐Ÿ˜ž negative with no growth results.

    Other terms

    The user has been using finasteride and dutasteride for hair loss but is experiencing low energy and motivation, possibly due to high prolactin levels. Despite treatment, hairline recession continues, and the user is considering the impact of low DHT levels on overall health and energy.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

      community Dutasteride 1 year regression. Depressing. (With pictures for proof)

      in Progress Pictures  14 upvotes 2 years ago
      A user shared their experience of hair loss progression after one year on dutasteride, expressing disappointment with no improvement and considering other treatments like RU58841. Other users offered mixed responses, some seeing no change, others suggesting the hair loss might have been worse without treatment, and discussing the role of testosterone and DHT in hair loss.

      community Creatine's effect on Hair Loss and DHT

      in Research/Science  101 upvotes 2 years ago
      A 21-year-old male managed to control his hair loss using Nizoral, RU58841, and finasteride, but experienced increased scalp itchiness after starting creatine, which subsided upon stopping creatine. Users shared mixed experiences on whether creatine affects hair loss, with some reporting negative effects and others seeing no change or defending its benefits.

    Related Research

    6 / 1000+ results
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: A Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
      Interventions for Female Pattern Hair Loss

      research Interventions for Female Pattern Hair Loss

      21 citations , May 2016 in “The Cochrane library”
      Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      The Endocrinology of Baldness

      research The Endocrinology of Baldness

      19 citations , April 2014 in “Hormones”
      Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.
      Androgenetic Alopecia

      research Androgenetic Alopecia

      April 2012 in “Informa Healthcare eBooks”
      AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.